NEW YORK (GenomeWeb) – Two shareholders have filed a class action lawsuit against Illumina and two of its top officials, claiming that the defendants made materially false and misleading statements regarding the firm's business, operations, and prospects between the announcement of Illumina's second quarter and preliminary third quarter financial results that led to an inflated share price.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.